Hematology Center
Sideroblastic Anemias

Home

Bleeding Patient
Reversing Coumadin
Reversing Heparin
Laboratory Tests in Hematology
Laboratory Tests In Coagulation
Aceruloplasminemia
African Iron Overload
Anemia, microcytic
Antiphospholipid Syndrome
Anemia, Microcytic, real cases
ATIII Deficiency
Atransferrinemia
Aplastic Anemia
B12 deficiency
Basophilia
Coagulation and Cancer
DIC
Essential Thrombocytosis
ENZYME DISORDERS (RBC)
Eosinophilia
Folate Deficiency
Hemoglobinoapthies
Hemoglobin S/C
Hemoglobin S/S
Hemolytic Anemia
Hemochromatosis
Hemophilia
Hemostasis
Heparins
Heparin-induced thrombocytopenia
Hypercoagulable States
Hyper-Ferritinemia
ITP
Iron Chelation
IRON DEFICIENCY
IRON OVERLOAD
IRON STUDIES
Liver and hemostasis
Megaloblastic Anemia
Monocytosis
Myleofibrosis with Myeloid Metaplasia
Neutrophil Structure
vWF
Porphyria
Phorphyrias (AIP)
Phorphyrias (AIP)
Polycythemia Vera
Prothrombin 20210A
RBC Membrane Disorders
Sickle Cell
Sideroblastic Anemias
Syndromes
TTP
Thalassemia
Thrombocytopenia, congenital
Wilson's Disease
Immunological markers
Amicar
Anagrelide
Oral Anticoagulants
Refludan

What is a sideroblast:
A nucleated red cell that has a stainable iron!

Sideroblastic Anemias:
Usually microcytic
Occasionally macrocytic
High iron/ferritin
Ineffective erythropoiesis
Mild hepatosplenomegaly (in hereditary SA, usually X-linked)

--------------------------------------------------------------------------

Heterogenous group of disorders-characterized by presence of amorphous iron deposits in the form of ferric phosphate & ferric hydroxide in the erythroblast mitochondria.
Note that a ringed sideroblast is a nucleated red cell in which large prussian blue-positive granules form a full or partial ring around the nucleus.
Sideroblastic anemias are characterized y ineffective erythropiesis.
1. Erythroid hyperplasia in the bone marrow
2. Normal or slightly increased reticulocyte count
3. Hypochromic & microcytic erythorcytes
4. Often dimorphism is pronounced
5. The siderotic mitochondria of developing cells may be retained in some circulating red cells -pappenhemier bodies- which are pathognomonic siderocytes in the wright's stained blood smear.
6. Increased iron stores and erythropoietic hemochromatosis (more pronounced if patient does carry HFE mutations)

--------------------------------------------------------------------------
CLASSIFICATION:

1. HEREDITARY (these do not evolve into leukemia)

-X-linked **most common**
...............erythroid-specific delta aminolevulinic acid synthase gene defect.
-Autosomal dominant
-Autosomal recessive
-Congenital (sporadic, pearson marrow-pancreas syndrome, DIDMOAD syndrome)

2. ACQUIRED
-PRIMARY (CLONAL)
MDS,
myeloproliferative disorders,
hematologic malignacies,
chemotherapy related

-REVERSIBLE
Alcoholism
Drugs (isoniazid, chloramphenicol)
Toxins (lead)
Copper deficiency - zinc overload
Hypothermia

--------------------------------------------------------------------------

MANAGEMENT

1. Treat the underlying disease
2. Vitamin B6 trial 200 mg qd for two months. If it worked, then taper down to prevent the potential neurotoxicity
3. Transfusions, if necessary + Iron chelation
4. Folic acid (may or may not be helpful)
5. Bone marrow transplantation (i.e. MDS patients)
6. Family Survery